• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reduction of blood lipid by berberine in hyperlipidemic patients with chronic hepatitis or liver cirrhosis.

作者信息

Zhao Wei, Xue Rong, Zhou Zhen-Xian, Kong Wei-Jia, Jiang Jian-Dong

出版信息

Biomed Pharmacother. 2008 Dec;62(10):730-1. doi: 10.1016/j.biopha.2008.01.007. Epub 2008 Feb 20.

DOI:10.1016/j.biopha.2008.01.007
PMID:18337056
Abstract
摘要

相似文献

1
Reduction of blood lipid by berberine in hyperlipidemic patients with chronic hepatitis or liver cirrhosis.黄连素对慢性肝炎或肝硬化高脂血症患者的血脂降低作用。
Biomed Pharmacother. 2008 Dec;62(10):730-1. doi: 10.1016/j.biopha.2008.01.007. Epub 2008 Feb 20.
2
Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.在慢性乙型或丙型肝炎患者对抗病毒治疗实现持续病毒学应答后，肝病严重程度可预测血糖异常的发生。
J Med Virol. 2009 Apr;81(4):610-8. doi: 10.1002/jmv.21396.
3
[Clinical trial of heptral in patients with chronic diffuse liver disease with intrahepatic cholestasis syndrome].[用贺普丁治疗慢性弥漫性肝病伴肝内胆汁淤积综合征患者的临床试验]
Klin Med (Mosk). 1998;76(10):45-8.
4
[Efficacy of chophytol in complex treatment of patients with the chronic forms of hepatitis and cirrhosis of viral etiology].[叶绿醇在病毒性病因慢性肝炎和肝硬化患者综合治疗中的疗效]
Georgian Med News. 2006 Jun(135):95-8.
5
[Dynamics of the pathomorphological changes in cirrhotic liver in own material].[自身材料中肝硬化肝脏病理形态学变化的动态研究]
Przegl Epidemiol. 2005;59(2):411-4.
6
Hepatitis A vaccine is not required in adult patients with chronic liver disease in Saudi Arabia.在沙特阿拉伯，慢性肝病成年患者无需接种甲型肝炎疫苗。
Singapore Med J. 2009 Apr;50(4):442-3.
7
[Clinical observation on effect of shennong xian'ganling capsule in treating chronic hepatitis and liver cirrhosis].神农仙肝灵胶囊治疗慢性肝炎及肝硬化的疗效临床观察
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2004 May;24(5):450-2.
8
Serum thrombopoietin levels in thrombocytopenic patients with liver cirrhosis.肝硬化血小板减少患者的血清血小板生成素水平
Haematologica. 2002 Aug;87(8):890-1.
9
[Effect of Ursodeoxycholi acid on liver cirrhosis with hepatitis B].
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Feb;35(2):171-5. doi: 10.3969/j.issn.1672-7347.2010.02.014.
10
[Liver hemosiderosis study in chronic viral hepatitis].[慢性病毒性肝炎中的肝脏含铁血黄素沉着症研究]
Rev Med Chir Soc Med Nat Iasi. 2008 Oct-Dec;112(4):914-21.

引用本文的文献

1
Pharmacological properties and therapeutic potential of berberine: a comprehensive review.小檗碱的药理特性与治疗潜力：综述
Front Pharmacol. 2025 Aug 14;16:1604071. doi: 10.3389/fphar.2025.1604071. eCollection 2025.
2
Berberine protects hepatocyte from hypoxia/reoxygenation-induced injury through inhibiting circDNTTIP2.小檗碱通过抑制 circDNTTIP2 保护肝细胞免受低氧/复氧诱导的损伤。
PeerJ. 2023 Sep 25;11:e16080. doi: 10.7717/peerj.16080. eCollection 2023.
3
Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism.
小檗碱抗代谢综合征相关肾脏疾病的研究进展：关于作用及机制
Front Pharmacol. 2023 Feb 6;14:1112088. doi: 10.3389/fphar.2023.1112088. eCollection 2023.
4
The effects of berberine supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis.补充小檗碱对成人心血管危险因素的影响：一项系统评价和剂量反应荟萃分析。
Front Nutr. 2022 Oct 14;9:1013055. doi: 10.3389/fnut.2022.1013055. eCollection 2022.
5
Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora.黄连素对肝纤维化的治疗作用与脂质代谢和肠道菌群有关。
Front Pharmacol. 2022 Mar 2;13:814871. doi: 10.3389/fphar.2022.814871. eCollection 2022.
6
Berberine and its derivatives represent as the promising therapeutic agents for inflammatory disorders.小檗碱及其衍生物是治疗炎症性疾病的有前途的治疗剂。
Pharmacol Rep. 2022 Apr;74(2):297-309. doi: 10.1007/s43440-021-00348-7. Epub 2022 Jan 27.
7
A Novel Promising Frontier for Human Health: The Beneficial Effects of Nutraceuticals in Cardiovascular Diseases.营养药物在心血管疾病中的有益作用：人类健康的新前沿领域
Int J Mol Sci. 2020 Nov 18;21(22):8706. doi: 10.3390/ijms21228706.
8
Berberine chloride suppresses non-small cell lung cancer by deregulating Sin3A/TOP2B pathway in vitro and in vivo.盐酸小檗碱通过体外和体内调控 Sin3A/TOP2B 通路抑制非小细胞肺癌。
Cancer Chemother Pharmacol. 2020 Jul;86(1):151-161. doi: 10.1007/s00280-020-04050-y. Epub 2020 Jun 30.
9
Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases.肝脏靶向纳米技术促进小檗碱改善心代谢疾病。
Nat Commun. 2019 Apr 30;10(1):1981. doi: 10.1038/s41467-019-09852-0.
10
Barberry in the treatment of obesity and metabolic syndrome: possible mechanisms of action.小檗碱治疗肥胖症和代谢综合征：可能的作用机制
Diabetes Metab Syndr Obes. 2018 Nov 8;11:699-705. doi: 10.2147/DMSO.S181572. eCollection 2018.